PMV Pharma Offering Consists of 22.1M Shrs, Prefunded Warrants for Some Investors to Buy 19.9M Shrs in Lieu of Common Stk >PMVP

Dow Jones2026/09/01 03:18

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Refinery to the world: Energy expert Anas Alhajji on India's surprising fuel advantage

EconomicTimes•2026/09/01 04:00

Inari Amertron Target Price Raised to MYR2.77 From MYR2.72 by Kenanga IB>0166.KU

Dow Jones•2026/09/01 03:43

PMV Pharma: TD Cowen Is Sole Bookrunning Manager >PMVP

Dow Jones•2026/09/01 03:38

PMV Pharma Expects Offering to Close on or About Sept. 2 >PMVP

Dow Jones•2026/09/01 03:38